← SynDRA
GRISEOFULVIN
SynDRA canonical compound SYN0000842 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | KRT12 |
|---|
| Mechanism of action | tubulin polymerization inhibitor |
|---|
| Indication | ringworm | tinea pedis |
|---|
| Disease area | infectious disease |
|---|
All known targets
- CYP51A1
- KRT12
- SLC22A1
- TUB2
Mechanisms of action (all sources)
- tubulin polymerization inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ESR2
- PDE3A
- NR1I2
- ESR1
- MMP9
- MC3R
- MC4R
- MC5R
- MLNR
- MMP1
- ACHE
- MAPK14
- NFE2L2
- NPY1R
- NPY2R
- NR3C1
- MAPK3
- MAOA
- MAPK1
- OPRK1
- LCK
- KDM4E
- KCNH2
- IDH1
- HTT
- HTR6
- HTR3A
- HTR2C
- HTR2B
- HTR2A
- HTR1A
- HSD17B10
- OPRD1
- OPRM1
- HRH1
- SIGMAR1
- TSHR
- TDP1
- TBXAS1
- TBXA2R
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ANDR
- CASP3
- VDR
- ULA1
- UBE2M
- TP53
- SMAD3
- SMAD2
- RARA
- PRGR
- NR1H4
- ITA4
- GPR151
- GLI3
- ESRRA
- CP3A7
- CP3A4
- CP2CJ
- CP2C9
- CP19A
- CASP7
- YAP1
Drug classes
- Anti-Infective Agents
- Antifungal Agents
- Tubulin Inhibiting Agent
ATC classes
- D01A · ANTIFUNGALS FOR TOPICAL USE
- D01B · ANTIFUNGALS FOR SYSTEMIC USE
Cross-references
Synonyms
- FULVICIN P/G
- FULVICIN P/G 165
- FULVICIN P/G 330
- FULVICIN-U/F
- Fulvicin P/G
- GRIFULVIN V
- GRIS-PEG
- GRISACTIN
- GRISACTIN ULTRA
- GRISEOFULVIN, ULTRAMICROSIZE
- GRISEOFULVIN,ULTRAMICROSIZE
- griseofulvin, microcrystalline
- (+)-Griseofulvin
- grisefulin
- griseofulvin, ultramicrocrystalline
- griseofulvin, ultramicrosize
- griseofulvin, microsize
- Griseofulvin, microcrystalline
- Griseofulvin, microsize
- Griseofulvin, ultramicrocrystalline
- Griseofulvin, ultramicrosize
- Griseofulvine
- Griseofulvina
- Grisactin v
- Griseofulvin microsize
- Griseofulvin,microsize
- Griseofulvinum
- NSC-34533
- NSC-755822
- Fulcin
- Fulcin 125
- Fulcin 500
- Fulsovin
- Fulvicin p/g
- Fulvicin p/g 165
- Fulvicin p/g 330
- Fulvicin-u/f
Reported adverse events
Look up GRISEOFULVIN in the interactive SynDRA portal →